Japan vs Tunisia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Japan
96.0%
in 2025
Tunisia
96.0%
in 2025
Japan rank
26th
Tunisia rank
26th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Japan
- Tunisia
How they compare
Japan currently reports 96.0% against 96.0% in Tunisia, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Tunisia ahead.
Japan ranks 26th and Tunisia ranks 26th of 192 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Japan | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | β |
| 2010s | 88.1% | 0.0% | 88.1% | Japan |
| 2020s | 95.3% | 95.2% | 0.2% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Japan or Tunisia?
- Japan, at 96.0% against 96.0% in Tunisia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Japan and Tunisia?
- 0.0%, with Japan ahead.
- How many years of comparable data are there for Japan and Tunisia?
- 18 years are reported by both, from 2008 to 2025.
- How do Japan and Tunisia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Japan ranks 26th and Tunisia ranks 26th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.